Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction

2013 ◽  
Vol 24 (6) ◽  
pp. 522-526 ◽  
Author(s):  
Jing-Gang Xia ◽  
Yang Qu ◽  
Hong Shen ◽  
Xiu-Hua Liu
Keyword(s):  
Myocardial Infarction ◽  
Alternative Therapy ◽  
St Elevation Myocardial Infarction ◽  
Drug Eluting Stent ◽  
Short Term ◽  
Urgent Surgery ◽  
Drug Eluting ◽  
St Elevation

scholarly journals Severe thrombocytopenia soon after drug-eluting stent implantation in ST-elevation myocardial infarction

2015 ◽  
Vol 4 ◽  
pp. 354-356
Author(s):  
Agnieszka Łebek-Szatańska ◽  
Anna Pośnik-Kisło ◽  
Wiesława Błaszak-Ciećwierska ◽  
Marek Dąbrowski
Keyword(s):  
Myocardial Infarction ◽  
Stent Implantation ◽  
St Elevation Myocardial Infarction ◽  
Drug Eluting Stent ◽  
Severe Thrombocytopenia ◽  
Drug Eluting ◽  
St Elevation

Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction

2010 ◽  
Vol 143 (3) ◽  
pp. 283-288 ◽  
Author(s):  
R. Gurvitch ◽  
J. Lefkovits ◽  
R.J. Warren ◽  
S.J. Duffy ◽  
D.J. Clark ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Clinical Outcomes ◽  
St Elevation Myocardial Infarction ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
St Elevation

scholarly journals Long-Term Outcomes with Selective Drug Eluting Stent Use in ST-Elevation Myocardial Infarction in an Australian Urban Population

2013 ◽  
Vol 22 ◽  
pp. S141
Author(s):  
J. Dandach ◽  
D. Changsirivathanathamrong ◽  
A. Narayan ◽  
J. Sullivan ◽  
A. Ong ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Urban Population ◽  
St Elevation Myocardial Infarction ◽  
Drug Eluting Stent ◽  
Long Term Outcomes ◽  
Drug Eluting ◽  
St Elevation

scholarly journals Prognostic Analysis of Patients with Acute Myocardial Infarction Undergoing Implantation of Different Stents for the First Time

2021 ◽  
Vol 10 (21) ◽  
pp. 5093
Author(s):  
Cheng-Chung Cheng ◽  
Fang-Han Yu ◽  
Pi-Shao Ko ◽  
Hsiao-Ting Lin ◽  
Wei-Shiang Lin ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Bare Metal Stents ◽  
St Elevation Myocardial Infarction ◽  
Drug Eluting Stents ◽  
Drug Eluting Stent ◽  
Metal Stents ◽  
Bare Metal ◽  
Different Types ◽  
Drug Eluting ◽  
St Elevation

For patients with acute myocardial infarction scheduled to undergo percutaneous coronary stent implantation, in most cases a drug-eluting stent is recommended as the first choice for treatment. However, there is a lack of research on the effectiveness of bare-metal stents and drug-eluting stents on patients with different types of myocardial infarction. Our objective was to explore the effects of bare-metal stents and drug-eluting stents on patients with different types of myocardial infarction in terms of major cardiovascular incidents. This retrospective cohort study included 934 patients with myocardial infarction undergoing coronary artery stent implantation for the first time at the cardiac catheter room of the Tri-Service General Hospital in the Neihu District between 2014 and 2018. Patients’ information, including demographic data, laboratory data, cardiac echocardiography results, and angiocardiography results, was collected by reviewing medical records. Cox proportional hazards regression was used to adjust the potential confounding factors, and the adjusted data were then used to compare the correlation between different types of stents and major cardiovascular incidents in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction. After the confounding factors were adjusted, in patients with ST-elevation myocardial infarction receiving a drug-eluting stent compared with those receiving a bare-metal stent, it was found that the mortality risk was lower in terms of all causes of death (Adj-HR = 0.26, 95% CI = 0.14–0.48, p < 0.001) and cardiogenic death (Adj-HR = 0.20, 95% CI = 0.08–0.55, p = 0.002), the risk of non-fatal myocardial infarction was lower (Adj-HR = 0.17, 95% CI = 0.04–0.73, p = 0.017), and there was no difference in the risk of revascularization at the lesion site (Adj-HR = 0.59, 95% CI = 0.24–1.43, p = 0.243). It terms of the findings in patients with non-ST-elevation myocardial infarction, those receiving a drug-eluting stent had a lower risk of revascularization at the lesion site (Adj-HR = 0.48, 95% CI = 0.24–0.97, p = 0.04); however, there was no difference in the mortality risk in terms of all causes of death (Adj-HR = 0.71, 95% CI = 0.37–1.35, p = 0.296) or cardiogenic death (Adj-HR = 0.59, 95% CI = 0.18–1.90, p = 0.379),or in the risk of non-fatal myocardial infarction (Adj-HR = 0.27, 95% CI = 0.06–1.25, p = 0.093). Compared with bare-metal stents, drug-eluting stents provide better protection against death to receivers with ST-elevation myocardial infarction; however, this protection is decreased in receivers with non-ST-elevation myocardial infarction. It is recommended that for patients with non-ST-elevation myocardial infarction who are indicated to receive a drug-eluting stent, the clinical effectiveness of the treatment must be considered.

Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction

2006 ◽  
Vol 7 (10) ◽  
pp. 771-774 ◽  
Author(s):  
Stefano Rigattieri ◽  
Roberto Patrizi ◽  
Pasquale Silvestri ◽  
Cristian Di Russo ◽  
Carmine Musto ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Primary Angioplasty ◽  
St Elevation Myocardial Infarction ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
St Elevation ◽  
Late Thrombosis
Sign in / Sign up

Export Citation Format

Share Document